FDA Approval History
This list consists of medications tracked by Drugs.com through the application and approval process at the U.S. Food and Drug Administration (FDA). Where possible, we have assembled information in chronological order to show the history of a medication. May only show partial information and does not include non-US drug approvals. For information about non-US medications, please visit the international drugs section.
Latest Drug Approvals
- Egaten (triclabendazole) - February 13, 2019
- Cablivi (caplacizumab-yhdp) - February 06, 2019
- Jeuveau (prabotulinumtoxinA-xvfs) - February 01, 2019
- Wixela Inhub (fluticasone propionate and salmeterol) - January 31, 2019
- Tosymra (sumatriptan) - January 25, 2019
- Ontruzant (trastuzumab-dttb) - January 18, 2019
- Elzonris (tagraxofusp-erzs) - December 21, 2018
- Inbrija (levodopa) - December 21, 2018
- ProAir Digihaler (albuterol sulfate) - December 21, 2018
- Ultomiris (ravulizumab-cwvz) - December 21, 2018
- Vaxelis (diphtheria and tetanus toxoids and acellular pertussis adsorbed, inactivated poliovirus, haemophilus b conjugate [meningococcal protein conjugate] and hepatitis B [recombinant] vaccine) - December 21, 2018
- Asparlas (calaspargase pegol-mknl) - December 20, 2018
- Herzuma (trastuzumab-pkrb) - December 14, 2018
- Motegrity (prucalopride) - December 14, 2018
- Tolsura (itraconazole) - December 11, 2018
- Dextenza (dexamethasone) - November 30, 2018
- Firdapse (amifampridine phosphate) - November 28, 2018
- Truxima (rituximab-abbs) - November 28, 2018
- Xospata (gilteritinib) - November 28, 2018
- Vitrakvi (larotrectinib) - November 26, 2018
